Skip to main content

Neeti Wilson speaks on ‘Patents, Innovation and Access to New Pharmaceuticals’ at the National Conference on IPR in Health Sciences organised by Amity University.

The two day conference, attended by over 150 participants, brought together speakers from the legal fraternity, government, and luminaries from the scientific community and academia.

Neeti spoke about the International System of Patenting and Indian patent law, with a focus on Section 3(d) of the Patents Act 1970.

In addition to talks on pharmaceutical patents and the role of regulation in health sciences, the conference envisaged discussion on topics ranging widely from IP in traditional medicine to patenting of cutting-edge medical developments such as regenerative medicines and stem cell research.neeti wilson amity university national conference ipr health sciences

Most Recent

News & Insights

VIEW ALL
News & Updates, Thought Leadership
Sep 11, 2026

Technology companies building in India are frequently told two contradictory things: that software cannot be patented in India, and that software patents

Software Patents in India Explained: What Can and Cannot Be Patented?
News & Updates, Thought Leadership
Sep 05, 2026

Written by: Dr. Ajai Garg and Siddhant Chamola As Artificial Intelligence has now emerged as a disruptive ecosystem reshaping Global economy,  India’s

India’s Pursuit for Global South AI Leadership through Agentic AI Systems: Navigating Intellectual Property Challenges
News & Updates, Thought Leadership
Sep 02, 2026

Author: Lakshmidevi Somanath The law currently provides creators exclusive rights over their creation for a limited time, which gives a human inventor

From Innovation Incentives to Technology Diffusion – Protection of Intellectual Property Created by Agentic Artificial Intelligence
News & Updates, Thought Leadership
Aug 30, 2026

I. The Infringer’s Privacy Paradox The Digital Personal Data Protection Act, 2023 (“DPDP Act”) is built around a clear rule. Personal data

The DPDP Act’s Unanswered Question: Can Privacy Law Block a Software Piracy Investigation?